United States-based Halodine LLC has collaborated with Emery Pharma, a boutique contract research and development company, it was reported on Thursday.

The collaboration is aimed at advancing the development of Halodine's proprietary antiseptic platform for COVID-19.

The partnership will see Emery Pharma's use its experience in antimicrobial and antiviral screening and drug development, while Halodine is to use its expertise in topical antiviral drug development.

Emery Pharma says that it will leverage its microbiology, virology, and bioanalytical experience to aid in developing this novel product, as well as other drugs to help treat COVID-19.